Head-to-head · Cost-Efficiency Index
Rixa Health vs Intimate Rose
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Rixa Health
Patients who want the broadest medication menu (including retatrutide) and don't mind price-after-visit disclosure.
Visit Rixa HealthIntimate Rose
Cost-first shoppers who want existing Intimate Rose pelvic-health customers curious about its bolt-on GLP-1 program, not comparison shoppers.
Visit Intimate RoseThe verdict
Rixa Health takes it, leading the Cost-Efficiency Index 54 to 53. Rixa Health is a telehealth GLP-1 clinic led by named medical director Timothy Scott, D.O., serving 45 states with a wide medication menu (compounded semaglutide, tirzepatide, an oral option, and retatrutide). Intimate Rose still earns a C — Cost-first shoppers who want existing Intimate Rose pelvic-health customers curious about its bolt-on GLP-1 program, not comparison shoppers.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Rixa Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Rixa Health | Intimate Rose |
|---|---|---|
| Cost-Efficiency Index | 54/100 | 53/100 |
| Semaglutide / mo | Not disclosed | $169/mo (starting dose, compounded) |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | $2,028 |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #363 | #368 |
Rixa Health
54/100Where the value is
- Named medical director with stated credentials (Timothy Scott, D.O.)
- 45-state coverage, among the widest of this batch
- LegitScript certified
The tradeoffs
- Zero pricing published anywhere on the public site -- cost is disclosed only after a paid/booked visit
- No named compounding pharmacy partner
Intimate Rose
53/100Where the value is
- A real, working GLP-1 telehealth funnel exists (not a dead link or vaporware page)
- The quiz states 'No payment to get started', so shoppers can get a personalized quote before committing
- Backed by an established, non-fly-by-night e-commerce brand with an existing customer base and content library
The tradeoffs
- GLP-1 is a secondary bolt-on to a pelvic-health device business, not this company's core competency — no dedicated GLP-1 clinical infrastructure is visible on the public site
- Only one undifferentiated price point ($169/month) is published — no dose tiers, no separate semaglutide vs. tirzepatide pricing, no fee itemization
Regulatory note: the FDA issued a warning letter to Intimate Rose in September 2025. We still list and link to Intimate Rose; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.